You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

EPIRUBICIN HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for epirubicin hydrochloride and what is the scope of freedom to operate?

Epirubicin hydrochloride is the generic ingredient in two branded drugs marketed by Pfizer Inc, Actavis Totowa, Cipla Ltd, Ebewe Pharma, Epic Pharma Llc, Fresenius Kabi Usa, Hikma, Hisun Pharm Hangzhou, Hospira, Impax Labs Inc, Norvium Bioscience, and Zennova, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for epirubicin hydrochloride. Two suppliers are listed for this compound.

Summary for EPIRUBICIN HYDROCHLORIDE
US Patents:0
Tradenames:2
Applicants:12
NDAs:15
Drug Master File Entries: 9
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 66
Clinical Trials: 475
Patent Applications: 7,142
What excipients (inactive ingredients) are in EPIRUBICIN HYDROCHLORIDE?EPIRUBICIN HYDROCHLORIDE excipients list
DailyMed Link:EPIRUBICIN HYDROCHLORIDE at DailyMed
Recent Clinical Trials for EPIRUBICIN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Jeeyun LeePhase 1/Phase 2
Daiichi SankyoPhase 3
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 1

See all EPIRUBICIN HYDROCHLORIDE clinical trials

Pharmacology for EPIRUBICIN HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for EPIRUBICIN HYDROCHLORIDE

US Patents and Regulatory Information for EPIRUBICIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065408-004 Oct 15, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065411-002 Aug 20, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride POWDER;INTRAVENOUS 050807-001 Sep 15, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065343-003 Apr 19, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ebewe Pharma EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065339-002 Dec 22, 2009 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065331-002 Aug 9, 2007 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.